OSINT

The clinical outcomes of the Melatonin studies to date have been favourable.

The eye-popping Mortality Relative Risk from the 2 RCTs is:

0.14, 95% CI [0.03-0.64], p=.011

[source]

446 views09:29

OSINT

Melatonin deficiency could be driving the COVID age vulnerability.

330 viewsedited 09:30

OSINT

Melatonin deficiency could be driving the COVID age vulnerability.

Another promise of Melatonin in COVID-19: it is a potent ferroptosis inhibitor, and ferroptosis might play a serious role in the severity of the disease.

https://onlinelibrary.wiley.com/doi/full/10.1002/ehf2.12958

Wiley Online Library

Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID‐19): autopsy reveals a ferroptosis signature

Aims
Cardiovascular complications, including myocarditis, are observed in coronavirus disease 2019 (COVID-19). Major cardiac involvement is a potentially lethal feature in severe cases. We sought to...

818 views09:31

Dr. Neel's presentation, May 10, 2021: High Dose Melatonin

Dr. Neel's presentation at the Toronto Doctors' Lounge Series. Dr. Neel has observed that among the COVID patients he has treated early, those patients do not manifest long hauler symptoms.

2.2K viewsedited 09:38

OSINT

Remarkably strong results of melatonin in a small US case study.

Melatonin looks exceptionally promising against COVID-19 but is terribly short of clinical trial results.

https://www.melatonin-research.net/index.php/MR/article/view/88

47 viewsedited 09:42

OSINT

Remarkably strong results of melatonin in a small US case study. Melatonin looks exceptionally promising against COVID-19 but is terribly short of clinical trial results. https://www.melatonin-research.net/index.php/MR/article/view/88

Melatonin in COVID-19 remains poorly researched to date, with the limited existing clinical trial data pointing to a substantial benefit: [source]

358 viewsedited 09:44

OSINT

https://www.biorxiv.org/content/10.1101/2021.03.10.432967v1.full

bioRxiv

Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response

The rapid spread of COVID-19 underscores the need for new treatments. Here we report that cannabidiol (CBD), a compound produced by the cannabis plant, inhibits SARS-CoV-2 infection. CBD and its metabolite, 7-OH-CBD, but not congeneric cannabinoids, potently…

337 views10:29

OSINT

https://app.powerbi.com/view?r=eyJrIjoiYmUwNmFhMjYtNGZhYS00NDk2LWFlMTAtOTg0OGNhNmFiNGM0IiwidCI6ImVlNGUxNDk5LTRhMzUtNGIyZS1hZDQ3LTVmM2NmOWRlODY2NiIsImMiOjh9

601 views11:55

Jefferey Jaxen & Del Bigtree Report Serious Antibody Drop After COVID-19 Inoculations

1.48K views12:54

OSINT

Jefferey Jaxen & Del Bigtree Report Serious Antibody Drop After COVID-19 Inoculations

"Acute, nonfulminant myocarditis, conversely, has a more indolent presentation with increased mortality up to 20% in the first year and 55% at 11 years based on initial diagnosis of acute myocarditis"

https://pubmed.ncbi.nlm.nih.gov/30637834/

PubMed

State of the art: Evaluation and prognostication of myocarditis using cardiac MRI - PubMed

Myocarditis encompasses both primary and secondary processes causing inflammation of the myocardium. Viral infections are a common secondary cause of myocarditis with important clinical relevance. Viral myocarditis has a varied clinical presentation, potentially…

188 views12:56

OSINT

https://www.jpost.com/health-and-wellness/coronavirus/antibody-levels-decrease-after-two-doses-of-pfizer-vaccine-study-681260

The Jerusalem Post

Antibody levels decrease after two doses of Pfizer vaccine - study

Over 4,800 staff members of Sheba participated in the study. They were invited to undergo periodical serological tests that measure the level of antibodies in the blood for a period of six months.

44 views12:58

OSINT

https://www.nejm.org/doi/full/10.1056/NEJMoa2114114